Skip to main content

Abstract

A 62-year-old female who is status post total hysterectomy and bilateral salphyngoopherectomy had the diagnosis of malignant mixed Müllerian tumor and is now being evaluated for restaging with 18F-FDG PET/CT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber WA, et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005;23:7445–53.

    Article  PubMed  Google Scholar 

  2. Bhoil A, Kashyap R, Bhattacharya A, Mittal BR. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of recurrent malignant mixed mullerian tumor. World J Nucl Med. 2014;13:64–6. doi:10.4103/1450-1147.138578.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Brennan MJ. Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage. 1992;7:110–6.

    Article  CAS  PubMed  Google Scholar 

  4. Chou HH, Chang TC, Yen TC, Ng KK, Hsueh S, Ma SY, et al. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol. 2006;24:123–8.

    Article  PubMed  Google Scholar 

  5. Funicelli L, Travaini LL, Landoni F, Trifirò G, Bonello L, Bellomi M. Peritoneal arcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT. Abdom Imaging. 2010;35:701–7. doi:10.1007/s00261-009-9578-8.

    Article  CAS  PubMed  Google Scholar 

  6. Herrera FG, Prior JO. The role of PET/CT in cervical cancer. Front Oncol. 2013;3:34. doi:10.3389/fonc.2013.00034.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Kanthan R, Senger JL. Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011;2011:470795 doi:10.1155/2011/470795

  8. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positronemission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28:2108–13.

    Article  PubMed  Google Scholar 

  9. Kim HW, Won KS, Zeon SK, Ahn BC, Gayed IW. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. Clin Nucl Med. 2013;38:93–7. doi:10.1097/RLU.0b013e31826390ec.

    Article  PubMed  Google Scholar 

  10. Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798–802.

    Article  CAS  PubMed  Google Scholar 

  11. Nishiyama Y, Yamamoto Y, Kanenishi K, Ohno M, Hata T, Kushida Y, et al. Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET. Eur J Nucl Med Mol Imaging. 2008;35:287–95.

    Article  PubMed  Google Scholar 

  12. Ozulker T, Ozulker F, Ozpacaci T. 99mTc-MDP and 18F-FDG uptake in calcified metastatic lesions from ovarian papillary serous adenocarcinoma. Hell J Nucl Med. 2009;12:287–8.

    PubMed  Google Scholar 

  13. Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, et al. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. Gynecol Oncol. 2008;109:255–62.

    Article  PubMed  Google Scholar 

  14. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, Ihling C, Högerle S, Mix M, et al. Metastatic lymph nodes in patients with cervical cancer:detection with MR imaging and FDG PET. Radiology. 2001;218:776–82.

    Article  CAS  PubMed  Google Scholar 

  15. Roh JW, Seo SS, Lee S, Kang KW, Kim SK, Sim JS, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study. Eur J Cancer. 2005;41:2086–92.

    Article  PubMed  Google Scholar 

  16. Rong-Hsin Yang, Yum-Kung Chu. 18F-FDG PET/CT findings of omental cake: a case report. Ann Nucl Med Sci. 2010;23:93–7.

    Google Scholar 

  17. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999;17:41–5.

    CAS  PubMed  Google Scholar 

  18. Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med. 2003;44:347–52.

    PubMed  Google Scholar 

  19. Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med. 2009;50 Suppl 1:64–73. doi:10.2967/jnumed.108.057257.

    Article  Google Scholar 

  20. Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006;238:272–9.

    Article  PubMed  Google Scholar 

  21. Tada H, Teramukai S, Fukushima M, Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47. doi:10.1186/1471-2407-9-47.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Wright JD, Dehdashti F, Herzog TJ, Mutch DG, Huettner PC, Rader JS, et al. Preoperative lymph node staging of early stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005;104:2484–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Özülker, T., Özülker, F. (2015). Gynecologic Tumors. In: Atlas of PET-CT Imaging in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18994-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18994-9_14

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18993-2

  • Online ISBN: 978-3-319-18994-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics